ACA
ROIV icon

Avoro Capital Advisors’s Roivant Sciences ROIV Stock Holding History

Avoro Capital Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,651,162
Closed -$49M – 45
2024
Q1 		$49M Hold
4,651,162
– – 0.57% 32
2023
Q4 		$52.2M Hold
4,651,162
– – 0.72% 23
2023
Q3 		$54.3M Sell
4,651,162
-1,155,000
-20% -$13.1M 0.85% 18
2023
Q2 		$58.5M Buy
+5,806,162
New +$51.9M 0.79% 22

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Avoro Capital Advisors's ROIV Position: Q2 2024 in Review

Avoro Capital Advisors sold out of Roivant Sciences (ROIV) in Q2 2024, closing a stake of 4,651,162 shares — an estimated $49M sold.

Avoro Capital Advisors first reported a position in ROIV in Q2 2023 and held it in 4 quarters. The position peaked at $58.5M in Q2 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q2 2024.

  • Avoro Capital Advisors reported no remaining Roivant Sciences position as of Q2 2024 after selling out during the quarter.
  • Avoro Capital Advisors sold 4,651,162 Roivant Sciences shares in Q2 2024, an estimated $49M.
  • Avoro Capital Advisors first reported a position in Roivant Sciences in Q2 2023 and held it in 4 quarters.
  • Avoro Capital Advisors's Roivant Sciences position peaked at $58.5M in Q2 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2024.

Based on Avoro Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.